Search
Search Funnelback University
1 -
10 of
27
search results for `lupus multiple sclerosis`
Fully-matching results
-
https://www.citiid.cam.ac.uk/wp-json/wp/v2/pages/8127
https://www.citiid.cam.ac.uk/wp-json/wp/v2/pages/8127They include tests for lupus, multiple sclerosis, diabetes mellitus and rheumatoid arthritis./pnpbProfessor Arthur Kaser/b/pn","protected":false},"excerpt":{"rendered":"pOne in every three-hundred people has inflammatory bowel disease -
Milner Affiliated company MedAnnex Ltd Receives SMART: SCOTLAND…
https://www.milner.cam.ac.uk/milner-affiliated-company-medannex-ltd-receives-smart-scotland-rd-award/There are well-known links between inflammation and several autoimmune conditions including rheumatoid arthritis, multiple sclerosis and systemic lupus erythematosus (“lupus”). -
Lect List 2008 215309
https://www.reporter.admin.cam.ac.uk/reporter/2008-09/special/01/pdfs/nat_sci_2.pdf18 Sep 2008: H. XUEREBClinico-anatomical correlation in multiple sclerosis. (Case. study) Tu. 28 Oct.DR M. ... CLATWORTHYSystemic lupus erythematosus I. W. 29 Oct. DR J. H. XUEREBGlomerulonephritis. -
School Winner: Busy Buzzing Bees | Murray Edwards College -…
https://www.murrayedwards.cam.ac.uk/news/our-blogs/she-talks-science/school-winner-busy-buzzing-bees3 Dec 2015: venom) has also helped many patients who suffer from serious conditions such as multiple sclerosis, arthritis and lupus. -
TH ER AP EU TIC S S YM PO ...
https://www.milner.cam.ac.uk/wp-content/uploads/2019/07/milner_symposium_final.pdf23 Jul 2019: TH. ER. AP. EU. TIC. S S. YM. PO. SIU. M 2019 B. UIL. DIN. G C. OL. LA. BO. RA. TIO. NS. TO. TR. AN. SF. OR. M T. HE. RA. PIE. S. THERAPEUTICS SYMPOSIUM 2019. BUILDING COLLABORATIONS TO TRANSFORM THERAPIES. Tuesday 25th June Cambridge Corn Exchange. -
Milner Symposium 2020 - Alliance
https://www.milner.cam.ac.uk/wp-content/uploads/2020/06/milner_symposium_2020-alliance-final.pdf9 Jun 2020: Astex is developing a proprietary pipeline of novel therapies and has multiple partnered products in development under collaborations with leading pharmaceutical companies. ... That’s why we produce all of our antibodies in-house and perform -
Legend
https://www.mrc-mbu.cam.ac.uk/files/impi-2021-q4pre-20211001-dist_0.xlsx4 Oct 2021: Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation [PMID:17384640]; DARS2 mutations in mitochondrial leucoencephalopathy and multiple sclerosis [PMID:19592391 -
ContentsMessage from the Head of School 2 Aims of ...
https://www.medschl.cam.ac.uk/wp-content/uploads/2022/01/CSM-Research_Overview_Jan_2022_Updated.pdf31 Jan 2022: New and innovative treatments of cancerWe are translating Cambridge laboratory discoveries into multiple new treatments of cancer. ... Our researchers are based within multiple sites within the Cambridge Biomedical Research Campus. -
Cambridge Enterprise invests in PredictImmune – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-invests-in-predictimmune/22 Feb 2023: The test has been validated in multiple, independent patient cohorts. The discovery and development of the test was partly funded by The Wellcome Trust which has agreed to further fund a ... Predictimmune will develop similar predictive tests for other -
Consultation Document on Schema Assumptions
https://www.jbs.cam.ac.uk/wp-content/uploads/2020/08/crs-geac-multiline-data-schema-consultation-document-phase-two-v0.9.pdf9 Jul 2023: such as cancer, multiple sclerosis or Parkinson’s disease. ... s) Multiple sclerosis. t) Muscular dystrophy. u) Obesity. v) Organ transplant.
Refine your results
Format
- 1 pdf
Date
- 18 Past year
- 16 Past 3 months
- 16 Past 6 months
- 16 2024
- 15 Past week
- 15 Past fortnight
- 15 Past month
- 14 Today
- 3 2023
- 2 Uncertain
- 1 2008
- 1 2019
- 1 Yesterday
- 1 2015
- 1 2022
- 1 2021
- 1 2020
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.